ホーム>>Signaling Pathways>> Others>>Rocuronium

Rocuronium

カタログ番号GC37552

ロクロニウム (Org-9426) は、現代の麻酔で使用されるアミノステロイド非脱分極神経筋遮断薬または筋弛緩薬です。

Products are for research use only. Not for human use. We do not sell to patients.

Rocuronium 化学構造

Cas No.: 143558-00-3

サイズ 価格 在庫数 個数
10mg
$73.00
在庫あり
50mg
$241.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Rocuronium (Org-9426) is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia.

[1]. Konishi J, Suzuki T, Kondo Y, Baba M, Ogawa S.Rocuronium and sugammadex used effectively for electroconvulsive therapy in a patient with Brugada syndrome.J ECT. 2012 Jun;28(2):e21-2. [2]. Zhang Y, Xiang Y, Liu J.Prevention of pain on injection of rocuronium: a comparison of lidocaine with different doses of parecoxib.J Clin Anesth. 2012 Jul 2. [3]. Suzuki T, Nameki K, Shimizu H, Shimizu Y, Nakamura R, Ogawa S.Efficacy of rocuronium and sugammadex in a patient with dermatomyositis.Br J Anaesth. 2012 Apr;108(4):703. [4]. Illodo Miramontes G, Doniz Campos M, Filgueira Garrido P, VÁzquez MartÍnez A.Rocuronium used in rapid sequence intubation and reversal with sugammadex in a patient with myasthenia gravis.Rev Esp Anestesiol Reanim. 2011 Dec;58(10):626-7. [5]. GarcÍa SÁnchez JI, MartÍnez Hurtado ED, Tordecilla Echenique YY, Santa-Ursula TJ.Rocuronium used after sugammadex.Rev Esp Anestesiol Reanim. 2011 Dec;58(10):620-1.

レビュー

Review for Rocuronium

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Rocuronium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.